Replicate NfL analysis in phase 3 multiple sclerosis - simvastatin trial 2 (MS-STAT2 trial). Develop novel biomarkers for neuroprotection independent of neuroinflammation. Explore mechanisms of simvastatin's effects on brain atrophy. The gene discussed is STAT2; the disease is Brain atrophy.